GENO-5

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameGENO-5
Drug Alias Nameprotein-subunit malaria vaccine (Genocea Biosciences/NMRC)
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Prophylactic vaccineNatural product/Extract +[4] 
Mechanisms of ActionT-cell surface antigen CD4 agonistsCluster of differentiation 8 stimulants
TargetsT-cell surface antigen CD4Cluster of differentiation 8
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenocea Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNaval Medical Research InstituteGenocea Biosciences Inc
Active IndicationsN/A
Inactive IndicationsMalaria

Other Information

ATC CodeN/A
Related LinksN/A